Register Now: From Clinical to Commercial: Accelerating ADC Late-Stage Development with Technology Innovation and Integrated Platform
|Articles|February 10, 2016

Metrohm USA Announces 2016 Young Chemist Award Winner

Metrohm USA awards the 2016 Young Chemist Award to PhD candidate developing wearable sensors that can non-invasively monitor physiologically relevant chemicals.

On Feb. 10, 2016 Metrohm USA announced the winner of the 2016 Young Chemist Award. The 2016 award was given to Amay Bandodkar, who is completing his PhD at the University of California San Diego, according to a press announcement from the company.

Bandodkar’s research focuses on developing wearable sensors that can non-invasively monitor physiologically relevant chemicals directly on the human body. He is developing specially engineered printable inks for fabricating smart printed devices that can be easily stretched and self-heal when mechanically damaged. The inks are then used to develop non-invasive wearable electrochemical devices for various healthcare applications.

This is the fourth year that Metrohm USA will give the $10,000 Young Chemist award. Amay will present a short overview of his work at Metrohm’s on-booth event at Pittcon 2016 on March 8, 2016 at 3 PM EST. 

Source: Metrohm USA


Related to this article

The BioPharm Brief: Cosentyx Approved in Polymyalgia Rheumatica, a Phase 3 Survival Win for an AML Vaccine, and $173 Million for In Vivo Bone Marrow Editing
FDA approves Novartis’ Cosentyx as the first anti-IL-17 biologic for polymyalgia rheumatica, SELLAS Life Sciences’ WT1-targeted peptide vaccine galinpepimut-S meets its overall survival primary endpoint in the phase 3 REGAL trial in AML, and Marrow Therapeutics launches with $173 million to develop bone marrow-targeted genetic medicines.